News

US subsidiary of Glenmark, Glenmark Generics has announced that it has settled all litigation pending between Glenmark and Medicis. The litigation were regarding the patent actions of Fluocinonide,

In one project, the National Human Genome Research Institute (NHGRI) will support work at ASU’s Biodesign Institute through a significant grant to boost research on rapid DNA sequencing

“We are very grateful and appreciative for ADDF’s support,” reported Dr. Joel Braunstein, managing member of C2N. “Beginning in 2008, ADDF provided funding to us at a vital

LyondellBasell Industries has launched Purell PE 3420F, a new low density polyethylene (LDPE) grade for use in pharmaceutical packaging. With a density of 0.933g/cm3, this product sets a

Schott has begun mass production of its Schott TopLyo pharmaceutical packaging for lyophilized (freeze-dried) drugs at its Muellheim, Germany facility. The Schott TopLyo packaging solution features a special

Wedgewood Pharmacy is compounding oseltamivir phosphate in a cherry-flavored suspension in response to the nationwide shortage of Tamiflu suspension. The commercially manufactured Tamiflu product, from F Hoffmann-La Roche,

NeurogesX has received approval from FDA for Qutenza (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to

Artes Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm have reported the successful production of a new target of a therapeutic protein. This is the first result

NovaDel Pharma (NovaDel) has enter into an exclusive license and distribution agreement with ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal to commercialise and manufacture ZolpiMist in the